AT
Aditya Tolia
Private Equity Senior Analyst
OrbiMed
Private Equity Senior Analyst at OrbiMed with prior Investec and PwC banking experience.
Bio
Professional summary
Sven H. Borho is a founder and Managing Partner of OrbiMed. His official profile says he heads the public equity team and serves as portfolio manager for OrbiMed’s public equity and hedge funds. He has been a portfolio manager for the firm’s funds since 1993 and has played an integral role in growing OrbiMed’s asset management activities. He began his career in 1991 at OrbiMed’s predecessor firm as a Senior Analyst covering European pharmaceutical firms and biotechnology companies worldwide. He studied business administration at Bayreuth University in Germany and received an MSc in Accounting and Finance from the London School of Economics.
Investment focus
Stage, sector, and overall fit
Stage
Public equityHedge funds
Sector
Life sciencesBiopharmaPharmaceuticalsBiotechnologyHealthcare public equities
Thesis
Public equity healthcare investingPublic equity and hedge fundsPharmaceutical companiesBiotechnology companies
How to approach
Framing and angles for outreach
Pitch framing
Lead with a public-markets-quality healthcare or biopharma thesis, emphasizing clinical, regulatory, commercial, and capital-markets relevance rather than a generic private venture pitch.
Personalization hooks
- 1Reference his long tenure managing OrbiMed funds since 1993.
- 2Emphasize rigorous life sciences, pharma, or biotech analysis aligned with his public equity background.
- 3For biopharma companies, frame the story around how public-market investors would evaluate clinical differentiation and commercial potential.
Recent signals
What the partner has said or done recently
Official profile identifies him as head of OrbiMed’s public equity team and portfolio manager for public equity and hedge funds.
Official profile states he has managed the firm’s funds since 1993.
Other partners at OrbiMed
12 more profiles
Alexis Megibow
Private Equity Associate
OrbiMed
Private Equity Associate at OrbiMed.
Ankesh Bhansali
Managing Director
OrbiMed
OrbiMed Asia Managing Director focused on healthcare private equity.
Arun Sadhanandham
Managing Director
OrbiMed
OrbiMed Asia Managing Director investing in healthcare private equity.
BC
Brendan Weber, CFA
Principal
OrbiMed
Principal on OrbiMed's Credit & Royalty team focused on structured credit and royalty financings.
CG
Carl Gordon
Managing Partner
OrbiMed
OrbiMed Managing Partner leading private equity and biotech company formation.
Carl L. Gordon
Managing Partner
OrbiMed
Carl L. Gordon is a Managing Partner at OrbiMed and leads the firm's private equity team.
CN
Carter Neild
Managing Partner
OrbiMed
OrbiMed Managing Partner focused on healthcare royalties and Asia private investments.
Clay Daniel DeMarcus
Principal
OrbiMed
Principal focused on medical technology and non-therapeutics venture investing.
CS
Cooper Steputis
Private Equity / Venture Capital
OrbiMed
Healthcare private equity and venture investor with prior investment banking experience.
Daniel Ying
Executive Director
OrbiMed
OrbiMed Asia Executive Director focused on pharma and biotech investments.
David Bonita
General Partner
OrbiMed
OrbiMed General Partner and physician-investor in healthcare and therapeutics.